top of page
NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
50242-0060-10 | J9035 | INJECTION, BEVACIZUMAB, 10 MG | AVASTIN (PF) 25 MG/1 ML | IV |
50242-0061-01 | J9035 | INJECTION, BEVACIZUMAB, 10 MG | AVASTIN (PF) 25 MG/ML | IV |
50242-0061-10 | J9035 | INJECTION, BEVACIZUMAB, 10 MG | AVASTIN (PF) 25 MG/1 ML | IV |
50242-0077-01 | J9356 | INJECTION, TRASTUZUMAB, 10 MG AND HYALURONIDASE-OYSK | HERCEPTIN HYLECTA (PF) 10000 U/5 ML-600 MG/5 ML | SC |
50242-0080-01 | J2778 | INJECTION, RANIBIZUMAB, 0.1 MG | LUCENTIS (INTRAVITREAL INJECTION) 0.5 MG/0.05 ML | IO |
50242-0080-02 | J2778 | INJECTION, RANIBIZUMAB, 0.1 MG | LUCENTIS (INTRAVITREAL INJECTION) 0.5 MG/0.05 ML | IO |
50242-0080-03 | J2778 | INJECTION, RANIBIZUMAB, 0.1 MG | LUCENTIS (INTRAVITREAL INJECTION) 0.5 MG/0.05 ML | IO |
50242-0082-02 | J2778 | INJECTION, RANIBIZUMAB, 0.1 MG | LUCENTIS (INTRAVITREAL INJECTION) 0.3 MG/0.05 ML | IO |
50242-0082-03 | J2778 | INJECTION, RANIBIZUMAB, 0.1 MG | LUCENTIS (INTRAVITREAL,PF) 0.3 MG/0.05 ML | IO |
50242-0085-27 | J2997 | INJECTION, ALTEPLASE RECOMBINANT, 1 MG | ACTIVASE (W/DILUENT) 100 MG | IV |
44206-0437-10 | J1459 | INJECTION, IMMUNE GLOBULIN (PRIVIGEN), INTRAVENOUS, NON-LYOPHILIZED (E.G. LIQUID), 500 MG | PRIVIGEN (PF,LATEX-FREE) 10% | IV |
44206-0438-20 | J1459 | INJECTION, IMMUNE GLOBULIN (PRIVIGEN), INTRAVENOUS, NON-LYOPHILIZED (E.G. LIQUID), 500 MG | PRIVIGEN (PF,LATEX-FREE) 10% | IV |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page